Literature DB >> 23902544

Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment.

Hidekazu Shirota, Dennis M Klinman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23902544     DOI： 10.2217/imt.13.70

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  4 in total

1.  Induction of liver-specific intrahepatic myeloid cells aggregation expands CD8 T cell and inhibits growth of murine hepatoma.

Authors:  Yung-Chang Lin; Chen-Yu Hsu; Sheng-Kai Huang; Yun-Han Fan; Chien-Hao Huang; Chan-Keng Yang; Wan-Ting Su; Po-Chia Chang; Avijit Dutta; Yu-Jen Liu; Ching-Tai Huang; Tse-Ching Chen; Chun-Yen Lin
Journal:  Oncoimmunology       Date:  2018-09-19       Impact factor: 8.110

Review 2.  Emerging nanotechnologies for cancer immunotherapy.

Authors:  Sourabh Shukla; Nicole F Steinmetz
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-04

3.  Antitumor and Adjuvant Activity of λ-carrageenan by Stimulating Immune Response in Cancer Immunotherapy.

Authors:  Min Luo; Bin Shao; Wen Nie; Xia-Wei Wei; Yu-Li Li; Bi-Lan Wang; Zhi-Yao He; Xiao Liang; Ting-Hong Ye; Yu-Quan Wei
Journal:  Sci Rep       Date:  2015-06-22       Impact factor: 4.379

Review 4.  Advancement of the Emerging Field of RNA Nanotechnology.

Authors:  Daniel Jasinski; Farzin Haque; Daniel W Binzel; Peixuan Guo
Journal:  ACS Nano       Date:  2017-02-07       Impact factor: 15.881
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.